SweeGen, Inc. announced that the U.S. Food and Drug Administration (FDA) issued a GRAS (Generally Recognized As Safe) No Objection Letter for BESTEVIA® Rebaudioside E ("Reb E") stevia leaf sweetener for use in foods. BESTEVIA e+ shows great success in reducing sugar and artificial sweeteners in many applications, such as beverage, dairy, sports nutrition, condiments and bakeries. BESTEVIA Reb E, SweeGen's non-caloric, high-purity stevia sweetener, is produced from the stevia leaf through a non-GMO bioconversion process. The FDA acknowledged in a letter dated June 21, 2019 that it evaluated the application and has no further questions regarding the conclusion that Reb E is GRAS under its intended use in foods. Reb E was commercialized at the end of 2018 and is available in large quantities. Having now received the No Objection Letter from the FDA, SweeGen will continue to pursue global approvals.